2 research outputs found
Relationship Between Duration of Type 2 Diabetes and Effectiveness of DPP-4 Inhibitor Versus Sulfonylurea as Add-on Therapy: A Post Hoc Analysis
<p><strong>Article full
text</strong></p>
<p><br>
The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s13300-017-0276-1"><b>here</b>.</a><br>
<br>
<strong>Provide enhanced digital features for this article</strong><br>
If you are an author of this publication and would like to provide additional enhanced
digital features for your article then please contact <u>[email protected]</u>.<br>
<br>
The journal offers a range of additional features designed to increase
visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.<br>
<br>
Other enhanced features include, but are
not limited to:<br>
• Slide decks<br>
• Videos and animations<br>
• Audio abstracts<br>
• Audio slides<u></u></p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p
The societal impact of early intensified treatment in patients with type 2 diabetes mellitus: Supplementary material
Aim: The current study estimates the societal impact of early intensified treatment compared with initial
monotherapy with subsequent treatment intensification in newly diagnosed adults with type 2 diabetes
mellitus in Mexico. Methods: An individual patient-level simulation and a static cohort model were
employed to simulate the treatment pathway and the probability of experiencing complications of
diabetes. The avoided number of events was translated into avoided productivity losses, which were
monetized using wages. Results: Patients on early intensified treatment experienced approximately
13,000 fewer complication events over 10 years. This was translated into a societal impact of $54 million
(USD). Conclusion: Early treatment intensification is likely to be of particular benefit to health outcomes
and productivity losses.</p